pirinixic acid has been researched along with Multiple Myeloma in 1 studies
pirinixic acid: structure
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, LH | 1 |
| Yang, XY | 1 |
| Zhang, X | 1 |
| Huang, J | 1 |
| Hou, J | 1 |
| Li, J | 1 |
| Xiong, H | 1 |
| Mihalic, K | 1 |
| Zhu, H | 1 |
| Xiao, W | 1 |
| Farrar, WL | 1 |
1 other study available for pirinixic acid and Multiple Myeloma
| Article | Year |
|---|---|
Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells.
Topics: Anilides; Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Marrow Cells; Cell Division; Cel | 2004 |